Ionic Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Ionic Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,117	Closed	-$72K	–	367
2021 Q2	$72K	Hold	20,117	–	–	0.01%	351
2021 Q1	$196K	Buy	+20,117	New	+$164K	0.03%	250

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ionic Capital Management's NRXPW Position: Q3 2021 in Review

Ionic Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q3 2021, closing a stake of 20,117 shares — an estimated $72K sold.

Ionic Capital Management first reported a position in NRXPW in Q1 2021 and held it in 2 quarters. The position peaked at $196K in Q1 2021. 5 funds tracked by Wall St. Rank hold NRXPW as of Q3 2021.

Ionic Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q3 2021 after selling out during the quarter.
Ionic Capital Management sold 20,117 NRX Pharmaceuticals Warrant shares in Q3 2021, an estimated $72K.
Ionic Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q1 2021 and held it in 2 quarters.
Ionic Capital Management's NRX Pharmaceuticals Warrant position peaked at $196K in Q1 2021.
5 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q3 2021.

Based on Ionic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.